EFiS   Report issue

Foundation Phase 2
Founded: Amsterdam Netherlands (1975)

Organization Overview

First Clinical Trial
2019
NCT04246723
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Scientific Center EFiS